Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression

Research in Veterinary Science

Volumn 85, Issue 1, 2008, Pages 56-61

  Wolfesberger, Birgitt ^a   Tonar, Zbynek ^b   Witter, Kirsti ^a   Guija de Arespacohaga, Abigail ^a   Skalicky, Monika ^a   Walter, Ingrid ^a   Thalhammer, Johann G ^a   Egger, Gunter F ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Canine lymphoma; Microvessel density; Normal lymph node; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD79A ANTIGEN; LECTIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CANCER CLASSIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG DISEASE; DRUG TARGETING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHOCYTE DIFFERENTIATION; LYMPHOMA; MICROVASCULATURE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION; LYMPH NODES; LYMPHOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CANIS FAMILIARIS;

EID: 43649097446     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.07.008     Document Type: Article

References (25)

1. Arias V., and Soares F.A. Vascular density (tumor angiogenesis) in non-Hodgkin's lymphomas and florid follicular hyperplasia. Leukemia and Lymphoma 40 (2000) 157-166
2. Bairey O., Zimra Y., Kaganovsky E., Shaklai E., Okon E., and Rabizadeh E. Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas. Medical Oncology 17 (2000) 314-318
3. Beecken W.D., Fernandez A., Joussen A.M., Achilles E.G., Flynn E., Lo K.M., Gillies S.D., Javaherian K., Folkman J., and Shing Y. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. Journal of the National Cancer Institute 93 (2001) 382-387
4. Carter R.F., Valli V.E., and Lumsden J.H. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Canadian Journal of Veterinary Research 50 (1986) 154-164
5. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., Siegel N.R., Leimgruber R.M., and Feder J. Tumor vesicular permeability factor stimulates endothelial cell growth and angiogenesis. Journal of Clinical Investigation 84 (1989) 1470-1478
6. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., and Augustin H.G. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Research 60 (2000) 1388-1393
7. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. Heterozygous embryonic lethality by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
8. Foss H.D., Araujo I., Demel G., Klotzbach H., Hummel M., and Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology 183 (1997) 44-50
9. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitary particles: the edge effect. Journal of Microscopy 111 (1977) 219-223
10. Hazar B., Paydas S., Zorludemir S., Sahin B., and Tuncer I. Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma. Leukemia and Lymphoma 44 (2003) 2089-2093
11. Hlatky L., Hahnfeldt P., and Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. Journal of National Cancer Institute 94 (2002) 883-893
12. Kadowaki I., Ichinohasama R., Harigae H., Ishizawa K., Okitsu Y., Kameoka J., and Sasaki T. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. British Journal of Haematology 130 (2005) 869-877
13. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362 (1993) 841-844
14. Koster A., van Krieken J.H., Mackenzie M.A., Schraders M., Borm G.F., van der Laak J.A., Leenders W., Hebeda K., and Raemaekers J.M. Increased vascularization predicts favourable outcome in follicular lymphoma. Clinical Cancer Research 11 (2005) 154-161
15. Mazur G., Wrobel T., Dziegiel P., Jelen M., Kuliczkowski K., and Zabel M. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma. Folia Histochemica et Cytobiologica 42 (2004) 241-243
16. Mazur G., Wozniak Z., Wrobel T., Maj J., and Kuliczkowski K. Increased angiogenesis in cutaneous T-cell lymphomas. Pathology Oncology Research 10 (2004) 34-36
17. Messick J.B., and Calderwood Mays M.B. Classification of lymphomas. In: Feldman B.F., Zinkl J.G., and Jain N.C. (Eds). Schalm's Veterinary Hematology. fifth ed (2000), Lippincott Williams & Wilkins, Philadelphia 604-613
18. Preusser M., Heinzl H., Gelpi E., Schonegger K., Haberler C., Birner P., Marosi C., Hegi M., Gorlia T., and Hainfellner J.A. Histopathologic assesment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 107 (2006) 162-170
19. Ranieri G., Patruno R., Lionetta A., Di Summa A., Mattioloi E., Bufo P., Pellecchia A., Ribatti D., and Zizzo N. Endothelial area and microvessel density in a canine non-Hodgkin's lymphoma: an intersecies model of tumor angiogenesis. Leukemia and Lymphoma 46 (2005) 1639-1643
20. Restucci B., Maiolino P., Paciello O., Martano M., De Vico G., and Papparella S. Evaluation of angiogenesis in canine seminomas by quantitative immunohistchemistry. Journal of Comparative Pathology 128 (2003) 252-259
21. Ribatti D., Vacca A., Nico B., Fanelli M., Roncali L., and Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas: an immunohistochemical and ultrastructure study. European Journal of Haematology 56 (1996) 45-53
22. Stewart M., Talks K., Leek R., Turley H., Pezzella F., Harris A., and Gatter K. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 40 (2002) 253-260
23. Tzankov A., Heiss S., Ebner S., Sterlacci W., Schaefer G., Augustin F., Fiegl M., and Dirnhofer S. Angiogenesis in nodal B cell lymphomas: a high throughput study. Journal of Clinical Pathology 60 (2007) 476-482
24. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New England Journal of Medicine 324 (1991) 1-8
25. Wolfesberger B., Guija de Arespacohaga A., Willmann M., Gerner W., Miller I., Schwendenwein I., Kleiter M., Egerbacher M., Thalhammer J.G., Muellauer L., Skalicky M., and Walter I. Expression of vascular endothelial growth factor and its receptors in canine lymphomas. Journal of Comparative Pathology 137 (2007) 30-40